Education
About Us
Working with TipRanks
Follow Us
MariMed Inc (MRMD)
OTHER OTC:MRMD
MRMD Stock Chart & Stats
$0.12
<$0.01(0.85%)
At close: 4:00 PM EST
$0.12
<$0.01(0.85%)
Day’s Range― - ―
52-Week Range$0.07 - $0.23
Previous CloseN/A
Volume101.75K
Average Volume (3M)1.40M
Market Cap
$56.89M
Enterprise Value$120.72M
Total Cash (Recent Filing)$6.60M
Total Debt (Recent Filing)$86.40M
Price to Earnings (P/E)―
Beta0.98
Next Earnings
Mar 11, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding395,073,640
10 Day Avg. Volume1,629,378
30 Day Avg. Volume1,398,937
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)0.71
Price to Sales (P/S)0.28
P/FCF Ratio-7.40
Enterprise Value/Market Cap2.12
Enterprise Value/Revenue0.77
Enterprise Value/Gross Profit2.00
Enterprise Value/Ebitda9.81
Forecast
1Y Price Target
$0.25Price Target Upside108.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MariMed News
MRMD FAQ
What was MariMed Inc’s price range in the past 12 months?
MariMed Inc lowest stock price was $0.07 and its highest was $0.23 in the past 12 months.
What is MariMed Inc’s market cap?
MariMed Inc’s market cap is $56.89M.
When is MariMed Inc’s upcoming earnings report date?
MariMed Inc’s upcoming earnings report date is Mar 11, 2026 which is in 82 days.
How were MariMed Inc’s earnings last quarter?
MariMed Inc released its earnings results on Nov 05, 2025. The company reported -$0.01 earnings per share for the quarter, the consensus estimate of -$0.01 by $0.
Is MariMed Inc overvalued?
According to Wall Street analysts MariMed Inc’s price is currently Undervalued.
Does MariMed Inc pay dividends?
MariMed Inc does not currently pay dividends.
What is MariMed Inc’s EPS estimate?
MariMed Inc’s EPS estimate is -0.01.
How many shares outstanding does MariMed Inc have?
MariMed Inc has 395,073,640 shares outstanding.
What happened to MariMed Inc’s price movement after its last earnings report?
MariMed Inc reported an EPS of -$0.01 in its last earnings report, expectations of -$0.01. Following the earnings report the stock price went down -9.091%.
Which hedge fund is a major shareholder of MariMed Inc?
Currently, no hedge funds are holding shares in MRMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MariMed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.25 (108.33% Upside)
$0.25 (108.33% Upside)
Insider Transactions
Bought Shares
Worth $4.5K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-10.58%
12-Months-Change
Fundamentals
Return on Equity
-24.41%
Trailing 12-Months
Asset Growth
-2.00%
Trailing 12-Months
Company Description
MariMed Inc
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
MRMD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a mix of positive and negative aspects. MariMed reported sequential growth in revenue and positive cash flow, driven by strong performance in Delaware and strategic expansion into the hemp market. However, challenges in retail revenue, increased net losses, and exit from the Missouri market indicate ongoing industry pressures.View all MRMD earnings summariesMRMD Stock 12 Month Forecast
Average Price Target
$0.25
▲(108.33% Upside)
Technical Analysis
cbdMD
―
Tilray
―
IM Cannabis Corp
―
Flora Growth
―
Incannex Healthcare Limited Sponsored ADR
―
Ownership Overview
10.73% Insiders
0.18% Other Institutional Investors
89.09% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---